Treatment with oral semaglutide (Rybelsus) significantly improved motivation measures in patients with major depressive ...

Four years after gaining FDA approval for Auvelity to treat major depressive disorder (MDD), Axsome Therapeutics has tacked ...

Does it matter when in childhood bullying happens? New research suggests recent bullying hits hardest and that early support ...

Canelo Alvarez reflected on his first career loss to Floyd Mayweather, admitting a possible ‘depressive’ stage after the 2013 ...

A robot-assisted form of heat-sensitive moxibustion may offer a new, non-drug way to support people recovering from methamphetamine dependence while experiencing depressive symptoms.

Alzheimer’s disease agitation could mean peak sales of over $2.1 billion for Axsome’s Auvelity, according to analysts at ...

ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of study ...

While many brain-computer interface companies are focused on helping paralyzed people communicate, Motif Neurotech is ...

A newer brain stimulation therapy matched ECT for depression while causing less memory loss, offering a potential option for patients concerned about cognitive side effects.

Magnetic seizure therapy appeared to beneficial for the treatment of major depressive disorder with fewer memory-related risks.

It’s a Tuesday afternoon in Brooklyn Heights, and Pamela has just arrived at her bachelorette party. It’s a peculiar one: The ...

Some psychedelic drugs, once considered fringe, are now getting a step closer to possibly being approved for use as mental ...